Evidence map›Paper›PMID 42066965›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2026

Fully Automated versus Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study.

Katie J McMenamin, Sergio Teruya, Jeremy Slivnick, Rabah Alreshq, Ikram Ullah, Denise Fine, Ali A Elzieny, Stephen Helmke, Cesia Gallegos, Edward J Miller and 4 more

Abstract read
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katie J McMenaminSection of Internal Medicine, Boston Medical Center, Boston, Massachusetts. Electronic address: katiejmcmenamin@gmail.com.
Sergio TeruyaColumbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York.
Jeremy SlivnickUniversity of Chicago Pritzker School of Medicine, Chicago, Illinois.
Rabah AlreshqSection of Cardiovascular Medicine, Boston Medical Center, Boston, Massachusetts.
Ikram UllahSection of Cardiovascular Medicine, Boston Medical Center, Boston, Massachusetts.
Denise FineSection of Cardiovascular Medicine, Boston Medical Center, Boston, Massachusetts.
Ali A ElzienyBoston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
Stephen HelmkeColumbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York.
Cesia GallegosYale University School of Medicine, New Haven, Connecticut.
Edward J MillerYale University School of Medicine, New Haven, Connecticut.
Federico M AschMedStar Health, Washington, District of Columbia.
Syeda HasanUniversity of Chicago Pritzker School of Medicine, Chicago, Illinois.
Mathew S MaurerColumbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York.
Frederick L RubergSection of Cardiovascular Medicine, Boston Medical Center, Boston, Massachusetts; Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.

Funding

SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations) COVID-19 SuppplementR01HL139671 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURER, MATHEW S, RUBERG, FREDERICK LIEF · 2019 to 2023
$7.4M
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac AmyloidosisR01AG081582 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATHEW S MAURER · 2023 to 2026
$2.8M
PRIMER: Promoting Research In MEdical ResidencyR38HL143584 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, Matthew G. Nayor · 2020 to 2026
$2.1M
Screening for Cardiac Amyloidosis with a Blood Biomarker in Minority Populations – SCABB-MPR01HL177670 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MATHEW S MAURER, Frederick Lief Ruberg · 2025 to 2026
$970k
NHLBI NIH HHS R01 HL139671NHLBI NIH HHS R01 HL177670NHLBI NIH HHS R38 HL143584NIA NIH HHS R01 AG081582
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42066965
PMCPMC13182997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.